Bound volatile general anesthetics alter both local protein dynamics and global protein stability

Anesthesiology

Volumn 90, Issue 1, 1999, Pages 235-245

  Johansson, Jonas S ^a,c   Zou, Helen ^b   Tanner, Jonathan W ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Anesthetic mechanisms; Anesthetic protein interaction; Fluorescence

Indexed keywords

1,2 DICHLORO 1,2,3,3,4,4 HEXAFLUOROCYCLOBUTANE; 1,2-DICHLORO-1,2,3,3,4,4-HEXAFLUOROCYCLOBUTANE; BOVINE SERUM ALBUMIN; CHLOROFLUOROCARBON; CYCLOBUTANE DERIVATIVE; HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; MYOGLOBIN; TRYPTOPHAN;

ALGORITHM; ANIMAL; ARTICLE; CATTLE; CHEMISTRY; CIRCULAR DICHROISM; FLUORESCENCE POLARIZATION; HUMAN; METABOLISM; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DENATURATION; TEMPERATURE;

ALGORITHMS; ANESTHETICS, INHALATION; ANIMALS; CATTLE; CHLOROFLUOROCARBONS; CIRCULAR DICHROISM; CYCLOBUTANES; FLUORESCENCE POLARIZATION; HALOTHANE; HUMANS; ISOFLURANE; MYOGLOBIN; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DENATURATION; SERUM ALBUMIN, BOVINE; TEMPERATURE; TRYPTOPHAN;

EID: 0032615797     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199901000-00030     Document Type: Article

References (50)

1. Eckenhoff RG, Johansson JS: Molecular interactions between inhaled anesthetics and proteins. Pharmacol Rev 1997; 49:343-67
2. Mihic SJ, Ye Q, Wick MJ, Koltchine W, Krasowski MD, Finn SE, Mascia MP, Valenzuela CF, Hanson KK, Greenblatt EP, Harris RA, Harrison NL: Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors. Nature 1997; 389:385-9
3. Jevtovic-Todorovic V, Todorovic SM, Mennerick S, Powell S, Dikranian K, Benshoff N, Zorumski CF, Olney JW: Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nature Med 1998; 4:460-3
4. 2) method for characterizing anesthetic binding to proteins: Analysis of isoflurane binding to albumin. Biochemistry 1992; 31:7069-76
5. Eckenhoff RG, Shuman H: Halothane binding to soluble proteins determined by photoaffinity labeling. ANESTHESIOLOGY 1993; 79:96-106
6. Johansson JS, Eckenhoff RG, Dutton PL: Binding of halothane to serum albumin demonstrated using tryptophan fluorescence. ANESTHESIOLOGY 1995; 83:316-24
7. Eckenhoff RG: Amino acid resolution of halothane binding sites in serum albumin. J Biol Chem 1996; 271:15521-6
8. Johansson JS: Binding of the volatile anesthetic chloroform to albumin demonstrated using tryptophan fluorescence quenching. J Biol Chem 1997; 272:17961-5
9. Peters T: Serum albumin. Adv Protein Chem 1985; 37:161-245
10. Johansson JS, Eckenhoff RG: Minimum structural requirement for an inhalational anesthetic binding site on a protein target. Biochim Biophys Acta 1996; 1290:63-8
11. Johansson JS, Rabanal F, Dutton PL: Binding of the volatile anesthetic halothane to the hydrophobic core of a tetra-α-helix bundle protein. J Pharmacol Exp Ther 1996; 279:56-61
12. Jardetzky O: Protein dynamics and conformational transitions in allosteric proteins. Prog Biophys Mol Biol 1996; 65:171-219
13. Demchenko AP: Fluorescence and dynamics in proteins, Topics in Fluorescence Spectroscopy, Volume 3, Biochemical Applications. Edited by Lakowicz JR. New York, Plenum Press, 1992, p 68
14. Lakowicz JR: Principles of Fluorescence Spectroscopy. New York, Plenum Press, 1983
15. Tanner JW, Eckenhoff RG, Liebman PA: Protein stabilization by an inhalational anesthetic agent (abstract). Biophys J 1997; 72:A417
16. Ueda I, Suzuki A: Irreversible phase transition of firefly luciferase: Contrasting effects of volatile anesthetics and myristic acid. Biochim Biophys Acta 1998; 1380:313-9
17. Postnikova GB, Komarov YE, Yumakova EM: Fluorescence study of the conformational properties of myoglobin structure. Eur J Biochem 1991; 198:223-32
18. Eftink M: Quenching-resolved emission anisotropy studies with single and multitryptophan-containing proteins. Biophys J 1983; 43: 323-34
19. Pace CN, Scholtz JM: Measuring the conformational stability of a protein, Protein Structure: A Practical Approach. 2nd edition. Edited by Creighton TE. Oxford, Oxford University Press, 1997, pp 299-321
20. Gonzalez L, Plecs JJ, Alber T: An engineered allosteric switch in leucine-zipper oligomerization. Nature Struct Biol 1996; 3:510-5
21. Johansson JS, Gibney BR, Rabanal F, Reddy KS, Dutton PL: A designed cavity in the hydrophobic core of a four-α-helix bundle improves volatile anesthetic binding affinity. Biochemistry 1998; 37: 1421-9
22. Koblin DD, Chortkoff BS, Laster MJ, Eger EI, Halsey MJ, Ionescu P: Polyhalogenated and perfluorinated compounds that disobey the Meyer-Overton hypothesis. Anesth Analg 1994; 79:1043-8
23. Forman SA, Raines DE: Nonanesthetic volatile drugs obey the Meyer-Overton correlation in two molecular protein site models. ANESTHESIOLOGY 1998; 88:1535-48
24. Eckenhoff RG, Tanner JW: Differential halothane binding and effects on serum albumin and myoglobin. Biophys J 1998; 75:477-83
25. Vitez TS, White PF, Eger EI: Effects of hypothermia on halothane MAC and isoflurane ALAC in the rat. ANESTHESIOLOGY 1974; 41:80-1
26. Strickland EH: Aromatic contributions to circular dichroism spectra of proteins. CRC Crit Rev Biochem 1972; 2:113-75
27. Shortle D, Meeker AK, Freire E: Stability mutants of Staphylococcal nuclease: Large compensating enthalpy-entropy changes for the reversible denaturation reaction. Biochemistry 1988; 27:4761-8
28. Frauenfelder H, Sligar SG, Wolynes PG: The energy landscapes and motions of proteins. Science 1991; 254:1598-1603
29. 19F-NMR study. Proc Natl Acad Sci U S A 1993; 90:6478-82
30. 19F nuclear magnetic resonance investigation of stereoselective binding of isoflurane to bovine serum albumin. Biophys J 1996; 70:532-8
31. Ueda I, Yamanaka M: Titration calorimetry of anesthetic-protein interaction: Negative enthalpy of binding and anesthetic potency. Biophys J 1997; 72:1812-7
32. Teichberg VI, Shinitzky M: Fluorescence polarization studies of lysozyme and lysozyme-saccharide complexes. J Mol Biol 1973; 74: 519-31
33. Lakowicz JR, Weber G: Nanosecond segmental mobilities of tryptophan residues in proteins observed by lifetime-resolved fluorescence anisotropies. Biophys J 1980; 32:591-601
34. Yguerabide J, Epstein HF, Stryer L: Segmental flexibility in an antibody molecule. J Mol Biol 1970; 51:573-90
35. Johansson JS: Nonanesthetic haloalkanes and nicotinic acetylcholine receptor desensitization kinetics (letter). ANESTHESIOLOGY 1996; 85:430-1
36. Pace CN, Shirley BA, McNutt M, Gajiwala K: Forces contributing to the conformational stability of proteins. FASEB J 1996; 10:75-83
37. Richards FM, Lim WA: An analysis of packing in the protein folding problem. Q Rev Biophys 1994; 26:423-98
38. Raines DE, Rankin SE, Miller KW: General anesthetics modify the kinetics of nicotinic acetylcholine receptor desensitization at clinically relevant concentrations. ANESTHESIOLOGY 1995; 82:276-87
39. 15N NMR. J Mol Biol 1995; 253:576-89
40. Gursky O, Fontano E, Bhyravbhatla B, Caspar DLD: Stereospecific dihaloalkane binding in a pH-sensitive cavity in cubic insulin crystals. Proc Natl Acad Sci U S A 1994; 91:12388-92
41. Büch HP, Altmeyer P, Büch U: Thiopental binding to human serum albumin in the presence of halothane. Acta Anaesthesiol Scand 1990; 34:35-40
42. Calvo R, Aguilera L, Suárez E, Rodriguez-Sasiaín JM: Displacement of warfarin from human serum albumin by halothane anaesthesia. Acta Anaesthesiol Scand 1989; 33:575-7
43. McDonagh AF, Pu YM, Lightner DA: Effect of volatile anesthetics on the circular dichroism of bilirubin bound to human serum albumin. Experientia 1992; 48:246-8
44. He XM, Carter DC: Atomic structure and chemistry of human serum albumin. Nature 1992; 358:209-15
45. Franks NP, Lieb WR: Do general anaesthetics act by competitive binding to specific receptors? Nature 1984; 310:599-601
46. Trudell JR: A unitary theory of anesthesia based on lateral phase separations in nerve membranes. ANESTHESIOLOGY 1977; 46:5-10
47. Lee J, Pilch PF, Shoelson SE, Scarlata SF: Conformational changes in the insulin receptor upon insulin binding and activation as monitored by fluorescence spectroscopy. Biochemistry 1997; 36:2701-8
48. Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, Gildehaus D, Miyashiro JM, Penning TD, Seibert K, Isakson PC, Stallings WC: Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 1996; 384:644-8
49. Silva JL, Weber G: Pressure stability of proteins. Annu Rev Phys Chem 1993; 44:89-113
50. Wann KT, MacDonald AG: Actions and interactions of high pressure and general anaesthetics. Prog Neurobiol 1988; 30:271-307